JM Acquires Cormetech
Johnson Matthey buys Cormetech for 360 million dollars, expanding its catalysts business
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Wall Street Slides as Alphabet Revenue Miss Revives AI Spending Jitters
U.S. stocks retreated Thursday as investors reassessed big tech’s AI spending after earnings, inflation data and the Federal Reserve’s policy decision.
M impact | EQUITY | Oct 29, 2026, 06:27 PM UTC
Alnylam Shares Fall About 26% on Demand and Pipeline Concerns
Alnylam signaled slower-than-expected demand growth for AMVUTTRA and pushed back certain trial results, while citing near-term Medicare Advantage restrictions and proposed drug rei
M impact | EQUITY | Oct 29, 2026, 06:26 PM UTC
Alphabet Shares Fall More Than 10%, Weighing on Nasdaq
Alphabet shares fell more than 10% Thursday after quarterly earnings missed Wall Street expectations, renewing concerns about returns on AI spending. The Nasdaq 100 fell about 1.3%
M impact | EQUITY | Oct 29, 2026, 06:26 PM UTC
Caterpillar Shares Fall 7.11% to $662.63
Caterpillar shares fell 7.11% to $662.63 at 10:34 a.m. ET on October 29.
M impact | EQUITY | Oct 29, 2026, 06:26 PM UTC
Alphabet Shares Fall 13% After Earnings Disappoint Investors
Alphabet shares were recently down 13%, putting the stock on course for its worst day ever and a potential loss of about half a trillion dollars in market value.
M impact | EQUITY | Oct 29, 2026, 06:23 PM UTC
Intel Shares Fall 2.8% Ahead of Scheduled Earnings Report
Intel shares traded at $92.855, down approximately 2.80% on Oct. 29, ahead of its scheduled earnings report after the 4 p.m. ET market close.
M impact | EQUITY | Oct 29, 2026, 06:21 PM UTC